Beneficient Files 8-K on Equity Sales and Bylaw Amendments
Ticker: BENF · Form: 8-K · Filed: 2026-04-10T07:40:52-04:00
Sentiment: neutral
Topics: unregistered-securities, corporate-governance, filing
TL;DR
Beneficient filed an 8-K for unregistered equity sales & bylaw changes. Watch for details.
AI Summary
On April 10, 2026, Beneficient filed an 8-K report detailing unregistered sales of equity securities under Item 3.02. The filing also includes amendments to articles of incorporation or bylaws under Item 5.03 and Regulation FD disclosures under Item 7.01. Specific details regarding the equity sales, amendments, or disclosures were not provided in the filing summary.
Why It Matters
This filing indicates potential changes in Beneficient's capital structure and corporate governance, which could impact existing shareholders and future investment opportunities.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities and amendments to corporate documents, which can introduce uncertainty and potential risks for investors.
Key Players & Entities
- Beneficient (company) — Filer of the 8-K report
- 0001775734 (company) — CIK number for Beneficient
- 0001493152-26-016035 (company) — SEC Accession Number for the filing
- 2026-04-10 (date) — Filing Date and Acceptance Date
- 2026-04-08 (date) — Period of Report
FAQ
What specific type of equity securities were sold unregistered?
The filing summary does not specify the type of equity securities sold unregistered, only that Item 3.02 pertains to 'Unregistered Sales of Equity Securities'.
What were the material modifications to the rights of security holders mentioned in Item 3.03?
The provided filing details do not elaborate on the specific material modifications to the rights of security holders under Item 3.03.
What specific amendments were made to Beneficient's Articles of Incorporation or Bylaws under Item 5.03?
The filing summary does not provide details on the specific amendments made to Beneficient's Articles of Incorporation or Bylaws under Item 5.03.
What information was disclosed under Regulation FD in Item 7.01?
The filing summary indicates a disclosure under Regulation FD (Item 7.01) but does not specify the content of that disclosure.
Are there any financial statements or exhibits included with this 8-K filing?
Yes, the filing lists several exhibits including EX-3.1 (likely Articles of Incorporation or Bylaws) and EX-99.1, along with various graphic files and XBRL data.
From the Filing
EDGAR Filing Documents for 0001493152-26-016035 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001493152-26-016035 Filing Date 2026-04-10 Accepted 2026-04-10 07:40:52 Documents 20 Period of Report 2026-04-08 Items Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K form8-k.htm iXBRL 8-K 75061 2 EX-3.1 ex3-1.htm EX-3.1 4325 3 GRAPHIC ex3-1_001.jpg GRAPHIC 364883 4 GRAPHIC ex3-1_002.jpg GRAPHIC 331428 5 GRAPHIC ex3-1_003.jpg GRAPHIC 350468 6 GRAPHIC ex3-1_004.jpg GRAPHIC 433319 7 GRAPHIC ex3-1_005.jpg GRAPHIC 424342 8 GRAPHIC ex3-1_006.jpg GRAPHIC 152856 9 EX-99.1 ex99-1.htm EX-99.1 31812 Complete submission text file 0001493152-26-016035.txt 3177257 Data Files Seq Description Document Type Size 10 XBRL SCHEMA FILE benf-20260408.xsd EX-101.SCH 4015 11 XBRL DEFINITION FILE benf-20260408_def.xml EX-101.DEF 26989 12 XBRL LABEL FILE benf-20260408_lab.xml EX-101.LAB 37467 13 XBRL PRESENTATION FILE benf-20260408_pre.xml EX-101.PRE 25613 23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6145 Mailing Address 325 N. SAINT PAUL STREET SUITE 4850 DALLAS TX 75201 Business Address 325 N. SAINT PAUL STREET SUITE 4850 DALLAS TX 75201 2144454705 Beneficient (Filer) CIK : 0001775734 (see all company filings) EIN. : 721573705 | State of Incorp.: NV | Fiscal Year End: 0331 Type: 8-K | Act: 34 | File No.: 001-41715 | Film No.: 26853175 SIC : 6199 Finance Services (CF Office: 02 Finance)